Endo buys Canada's Paladin to counter sliding sales

U.S.-based specialty pharmaceutical company Endo Health Solutions Inc will buy Canadian peer Paladin Labs Inc to expand its presence in Canada and emerging markets, as generic competition for its top drugs squeeze sales. The news sent Endo shares up as much as 33 percent, valuing Paladin - to be acquired in a cash and stock deal - at about $2 billion. The deal, Endo's biggest acquisition since its $2.9 billion purchase of American Medical Systems in June 2011, will help Endo to add more products to its pain and women's health portfolio, as well as reduce its tax burden. The complex deal structure will create a new Irish holding company, which will own both Endo and Paladin, to take advantage of Ireland's low tax rates.



via Health News Headlines - Yahoo! News http://news.yahoo.com/endo-health-buy-canadian-peer-paladin-labs-1-120011986--finance.html